MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Clinical trials for MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA trials appear
Sign up with your email to follow new studies for MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Personalized cell therapy trial offers new hope for Tough-to-Treat cancers
Disease control Recruiting nowThis study is testing a new type of cell therapy for people with advanced solid tumors that have stopped responding to standard treatments. Doctors will analyze a patient's tumor to select a specific target, then infuse specially engineered immune cells (CAR-NK cells) from a heal…
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Phase: PHASE1, PHASE2 • Sponsor: Essen Biotech • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
Pill vs. shot: new hope for preventing deadly clots in cancer patients
Prevention Recruiting nowThis study is testing if blood thinner pills (apixaban or rivaroxaban) are as safe and effective as standard daily shots (low-molecular-weight heparin) at preventing dangerous blood clots in people being treated for blood cancers like leukemia, lymphoma, or multiple myeloma. Abou…
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Phase: NA • Sponsor: Medical University of Gdansk • Aim: Prevention
Last updated Mar 27, 2026 12:39 UTC
-
Can a chatbot convince you to join a medical trial?
Knowledge-focused Recruiting nowThis study is testing whether an AI-powered chatbot can help patients with blood cancers like leukemia and lymphoma better understand clinical trials. Researchers want to see if this personalized, computer-based education increases patients' willingness to consider joining a tria…
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Phase: NA • Sponsor: Zhongnan Hospital • Aim: Knowledge-focused
Last updated Apr 01, 2026 14:41 UTC
-
Simple health checks may predict dangerous side effects for seniors getting powerful cancer therapies
Knowledge-focused Recruiting nowThis study aims to see if simple health checks before advanced cancer treatments can predict severe side effects in patients aged 65 and older. Researchers will test mobility, memory, and self-care skills in 208 older adults scheduled for CAR-T cell or bispecific antibody therapy…
Matched conditions: MULTIPLE MYELOMA (MM), LYMPHOMA, LARGE B-CELL, DIFFUSE (DLBCL), LYMPHOMA
Sponsor: University of Zurich • Aim: Knowledge-focused
Last updated Mar 31, 2026 12:12 UTC